Lupin gets US FDA nod for Dronedarone Tablets, USP EP News Bureau Feb 1, 2024 They are indicated to reduce the risk of hospitalisation for atrial fibrillation (AF) in patients in sinus rhythm with a history…
Atrial fibrillation market to decline during 2022-32: GlobalData EP News Bureau Jul 14, 2023 GlobalData’s report, “Atrial Fibrillation: Eight Market Drug Forecast and Market Analysis,” reveals that five late-stage pipeline…
Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients EP News Bureau Nov 4, 2014 The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…
